Thus, we could come to the first conclusion that CK-18-M30, FGF-21, IL-1Ra, PEDF and OPG were noninvasive diagnostic serum biomarkers for NAFLD and NASH. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.